Literature DB >> 9276862

The metabolic basis of cancer cachexia.

J M Argilés1, B Alvarez, F J López-Soriano.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9276862     DOI： 10.1002/(sici)1098-1128(199709)17:5<477::aid-med3>3.0.co;2-r

Source DB:  PubMed          Journal:  Med Res Rev        ISSN： 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  36 in total

1.  Nutritional treatment of cancer cachexia in rats. Use of a diet formulated with a crayfish enzymatic extract.

Authors:  Olga Cremades; Juan Parrado; María Jover; Laura Collantes de Terán; Juan Francisco Gutiérrez; Juan D Bautista Palomas
Journal:  Eur J Nutr       Date:  2007-08-04       Impact factor: 5.614

Review 2.  For whom the bell tolls? DING proteins in health and disease.

Authors:  Anne Berna; François Bernier; Eric Chabrière; Mikael Elias; Ken Scott; Andrew Suh
Journal:  Cell Mol Life Sci       Date:  2009-03-17       Impact factor: 9.261

3.  Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.

Authors:  Sílvia Busquets; Míriam Toledo; Sònia Sirisi; Marcel Orpí; Roberto Serpe; Joana Coutinho; Raquel Martínez; Josep M Argilés; Francisco J López-Soriano
Journal:  Exp Ther Med       Date:  2011-04-28       Impact factor: 2.447

Review 4.  The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia.

Authors:  Mit Joshi; Bhoomika M Patel
Journal:  Mol Cell Biochem       Date:  2022-03-07       Impact factor: 3.396

5.  Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats.

Authors:  Sílvia Busquets; Míriam Toledo; Enrica Marmonti; Marcel Orpí; Eva Capdevila; Angelica Betancourt; Francisco J López-Soriano; Josep M Argilés
Journal:  Oncol Lett       Date:  2011-10-13       Impact factor: 2.967

Review 6.  Mechanisms linking obesity and cancer.

Authors:  Sharon M Louie; Lindsay S Roberts; Daniel K Nomura
Journal:  Biochim Biophys Acta       Date:  2013-03-05

7.  Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance.

Authors:  Sílvia Busquets; Míriam Toledo; Marcel Orpí; David Massa; Maria Porta; Eva Capdevila; Núria Padilla; Valentina Frailis; Francisco J López-Soriano; H Q Han; Josep M Argilés
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-11-08       Impact factor: 12.910

8.  The role of insulin resistance in the development of muscle wasting during cancer cachexia.

Authors:  Mary A Honors; Kimberly P Kinzig
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-12-01       Impact factor: 12.910

9.  The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer.

Authors:  D A C Deans; B H Tan; S J Wigmore; J A Ross; A C de Beaux; S Paterson-Brown; K C H Fearon
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

10.  Theophylline is able to partially revert cachexia in tumour-bearing rats.

Authors:  Mireia Olivan; Jochen Springer; Sílvia Busquets; Anika Tschirner; Maite Figueras; Miriam Toledo; Cibely Fontes-Oliveira; Maria Inés Genovese; Paula Ventura da Silva; Angelica Sette; Francisco J López-Soriano; Stefan Anker; Josep M Argilés
Journal:  Nutr Metab (Lond)       Date:  2012-08-21       Impact factor: 4.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.